Whole genome sequencing has received a lot of attention recently from the media as the technology to analyze a person's entire genome has become more common and less expensive.

Heidi Rehm, director of the Laboratory of Molecular Medicine within Partners HealthCare Personalized Medicine spoke recently with The Boston Globe about the perceptions and realities of whole genome sequencing.

The public has a view of genome sequencing that may not line up exactly with the realities: finding a specific genetic mutation does not mean that one is destined to develop a specific disease or condition, and each lab that analyzes one's genes could produce different results. Rehm said that people should see a genetic test as one test that should be weight in combination with other factors, like symptoms and family history.

Read more from The Boston Globe.